Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).
Trial details
- Registry ID
- NCT03573401
- Drugs studied
- Photodynamic therapy (PDT) (ALA-PDT, Ameluz®-PDT)